1 | ACT-385781A (Actelion Epoprostenol) | 1件: Epoprostenol Epoprostenol | 1件: D00106
D00106
(Name: Epoprostenol) | 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 |
2 | Combination injection of EPO and G-CSF | 1件: Filgrastim Filgrastim | 1件: D03235
D03235
| 1件: CSF3R CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 1件: 6 6 |
3 | Current marketed FLOLAN (epoprostenol sodium) | 1件: Epoprostenol Epoprostenol | 1件: D00106
D00106
(Name: Epoprostenol) | 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 |
4 | EPO | - | - | - | - | 1件: 13 13 |
5 | Epoeitin beta | - | - | - | - | 1件: 18 18 |
6 | Epoetin alfa | 1件: Erythropoietin Erythropoietin (Synonym: Epoetin alfa rDNA) | - | - | - | 3件: 13 13, 18, 46 |
7 | Epoetin beta | 1件: Erythropoietin Erythropoietin (Synonym: Epoetin alfa rDNA) | - | - | - | 1件: 13 13 |
8 | EPOPROSTENOL | 1件: Epoprostenol Epoprostenol | 1件: D00106
D00106
(Name: Epoprostenol) | 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 |
9 | Epoprostenol for injection | 1件: Epoprostenol Epoprostenol | 1件: D00106
D00106
(Name: Epoprostenol) | 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 |
10 | EPOPROSTENOL SODICO | 1件: Epoprostenol Epoprostenol | 1件: D00106
D00106
(Name: Epoprostenol) | 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 |
11 | EPOPROSTENOL SODIUM | 1件: Epoprostenol Epoprostenol | 1件: D00106
D00106
(Name: Epoprostenol) | 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 |
12 | Epoprostenol-Actelion | 1件: Epoprostenol Epoprostenol | 1件: D00106
D00106
(Name: Epoprostenol) | 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 |
13 | Epoprostenolo per iniezione | - | - | - | - | 1件: 86 86 |
14 | Erythropoetin (EPO) | - | - | - | - | 1件: 2 2 |
15 | Erythropoietin human recombinant (EPOrh) | 1件: Erythropoietin Erythropoietin (Synonym: Epoetin alfa rDNA) | - | - | - | 1件: 6 6 |
16 | New thermo stable formulation of epoprostenol sodium | 1件: Epoprostenol Epoprostenol | 1件: D00106
D00106
(Name: Epoprostenol) | 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 |